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Abstract
Background: Pendred syndrome, a common autosomal-recessive disorder characterized by congenital
deafness and goiter, is caused by mutations of SLC26A4, which codes for pendrin. We investigated the
relationship between pendrin and deafness using mice that have (Slc26a4+/+) or lack a complete Slc26a4
gene (Slc26a4-/-).
Methods: Expression of pendrin and other proteins was determined by confocal immunocytochemistry.
Expression of mRNA was determined by quantitative RT-PCR. The endocochlear potential and the
endolymphatic K+  concentration were measured with double-barreled microelectrodes. Currents
generated by the stria marginal cells were recorded with a vibrating probe. Tissue masses were evaluated
by morphometric distance measurements and pigmentation was quantified by densitometry.
Results: Pendrin was found in the cochlea in apical membranes of spiral prominence cells and spindle-
shaped cells of stria vascularis, in outer sulcus and root cells. Endolymph volume in Slc26a4-/- mice was
increased and tissue masses in areas normally occupied by type I and II fibrocytes were reduced. Slc26a4-
/- mice lacked the endocochlear potential, which is generated across the basal cell barrier by the K+ channel
KCNJ10 localized in intermediate cells. Stria vascularis was hyperpigmented, suggesting unalleviated free
radical damage. The basal cell barrier appeared intact; intermediate cells and KCNJ10 mRNA were present
but KCNJ10 protein was absent. Endolymphatic K+ concentrations were normal and membrane proteins
necessary for K+ secretion were present, including the K+ channel KCNQ1 and KCNE1, Na+/2Cl-/K+
cotransporter SLC12A2 and the gap junction GJB2.
Conclusions: These observations demonstrate that pendrin dysfunction leads to a loss of KCNJ10
protein expression and a loss of the endocochlear potential, which may be the direct cause of deafness in
Pendred syndrome.
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Background
Pendred syndrome is a relatively common autosomal-
recessive disorder characterized by deafness and goiter [1].
The syndrome is caused by mutations of the PDS gene
SLC26A4, which codes for the protein pendrin [2]. Deaf-
ness is congenital and generally profound although some-
times late in onset and provoked by light head injury.
Vestibular dysfunction is uncommon. Goiter is variable
and generally develops around puberty [3]. The cause of
goiter appears to be an impairment of iodide fixation in
the follicular lumen due to a reduced rate of iodide trans-
port across the apical membrane of thyroid gland epithe-
lial cells [4]. A positive perchlorate discharge test and an
enlarged vestibular aqueduct appear to be the most relia-
ble clinical signs of Pendred syndrome [5].
Pendrin is an anion exchanger that can transport Cl-, I-,
HCO3 
- and formate [6,7]. Expression has been found in
the inner ear and thyroid gland consistent with the clinical
signs of deafness and goiter [2,3,8]. In addition, pendrin
expression has been found in the kidney [9], mammary
gland [10], uterus [11], testes [12] and placenta [13]. No
expression was found in fetal or adult brain, consistent
with a peripheral cause of deafness [2,11].
Expression of pendrin mRNA in the inner ear has been
found in several places including the cochlea, the vestibu-
lar labyrinth and the endolymphatic sac [8]. The precise
location of pendrin protein expression, however, has not
yet been determined. The variability of deafness in Pen-
dred syndrome and the observation that deafness is some-
times late in onset suggest that pendrin dysfunction may
not be the direct cause of deafness. It is conceivable that
pendrin dysfunction favors changes in the expression lev-
els of proteins that are critical for the maintenance of the
hearing function. Detailed studies aimed at identifying
the direct cause of deafness in Pendred syndrome have
recently become possible due to the generation of a pen-
drin-specific polyclonal antibody [9] and the develop-
ment of Slc26a4-/- mice, which bear a targeted disruption
of the mouse Slc26a4 gene [14]. The aim in the present
study was to determine the location of pendrin and the
cause of deafness in Slc26a4-/- mice.
Methods
The endocochlear potential and the endolymphatic and
perilymphatic K+ concentrations were measured in young
adult mice (1–4 month of age) that either have (Slc26a4+/
+) or lack (Slc26a4-/-) a functional gene for pendrin [14].
The mouse strain 129Sv/Ev (Taconic, Germantown, NY)
was chosen as the source of Slc26a4+/+ controls, since
Slc26a4-/- mice were propagated in the this strain and gen-
erated using a stem cell line derived from 129Sv/Ev.
Slc26a4+/+ and Slc26a4-/- were agouti. They did not differ in
coat color. Differences in pigmentation were verified
using coisogenic age-matched Slc26a4+/+ and  Slc26a4-/-
that were bred in parallel.
Expression of key proteins involved in the generation of
the endocochlear potential and the transport of K+ was
studied using confocal immunocytochemistry and quan-
titative RT-PCR. K+ secretion and the generation of the
endocochlear potential were measured using electrophys-
iological techniques. All experiments were approved by
the Institutional Animal Care and Use Committee of Kan-
sas State University.
Confocal immunocytochemistry
Animals were deeply anesthetized with sodium pentobar-
bital (100 mg/kg i.p.) and transcardially perfused with a
Cl--free phosphate-buffered Na-gluconate solution con-
taining 4% paraformaldehyde. Temporal bones were
removed and cochleae fixed by perilymphatic perfusion,
decalcified in EDTA, processed through a sucrose gradient
and infiltrated with polyethylene glycol. Mid-modiolar
cryosections (12 µm, CM3050S, Leica, Nussloch, Ger-
many) were blocked in PBS with 0.2% Triton-X (PBS-TX)
and 10% bovine serum albumin. Slides were incubated
overnight at 4°C with primary antibodies in PBS-TX with
1–3% BSA [rabbit anti-pendrin, 1:500 (h766–780); rat
anti-ZO-1, 1:100 (Chemicon, Temecula, CA); goat anti-
KCNQ1, 1:200 (C20, Santa Cruz Biotechnology, Santa
Cruz, CA), rabbit anti-KCNE1, 1:200 (Alomone, Jerusa-
lem, Israel); rabbit anti-KCNJ10, 1:300 (Alomone); rabbit
anti-SLC12A2, 1:100 (Chemicon); and rabbit anti-con-
nexin 26, 1:100 (Zymed, San Francisco, CA)]. Slides were
washed in PBS-TX and incubated for 1 h at 25°C with
appropriate secondary antibodies at a 1:1000 dilution in
PBS-TX with 1–3% BSA [donkey anti-rabbit Alexa 488,
chicken anti-rat Alexa 594, and chicken anti-goat Alexa
594 (Molecular Probes, Eugene, OR)]. Actin filaments
were visualized by staining with Alexa 488 conjugated
phalloidin (Molecular Probes). After incubation, slides
were washed with PBS-TX, mounted with FluorSave (Cal-
biochem, La Jolla, CA), and viewed by confocal micros-
copy (LSM 5 Pascal or LSM 510 Meta, Carl Zeiss, Jena or
Göttingen, Germany). Laser scanning brightfield images
were collected to document structural preservation, for
morphometric analysis and for analysis of pigmentation.
Quantitative RT-PCR
Animals were deeply anesthetized with sodium pentobar-
bital (100 mg/kg i.p.). Kidneys and brain were removed
and pulverized in liquid N2. Temporal bones were
removed and two preparations of inner ear tissues were
obtained by microdissection: (1) stria vascularis without
spiral ligament, and (2) spiral ganglia including the sur-
rounding bone and the organ of Corti. The dissection
medium was changed twice during the microdissection
and isolated tissues were washed three times to minimizeBMC Medicine 2004, 2:30 http://www.biomedcentral.com/1741-7015/2/30
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cross-contamination. The Slc26a4-/-genotype was verified
by the observation of large otoconia in the utricular mac-
ula [14]. Total RNA was isolated and residual DNA con-
tamination was removed by enzymatic digestion (RNeasy
micro, Qiagen, Valencia, CA). Quality and quantity of 18S
rRNA obtained from kidneys and brain were determined
(Nano Assay, 2100 Bioanalyzer, Agilent, Palo Alto, CA).
Further, the quality of RNA preparations obtained from
stria vascularis and spiral ganglia was assessed (Pico
Assay, 2100 Bioanalyzer). Real time RT-PCR was per-
formed on RNA obtained from individual animals
(OneStep RT-PCR, Qiagen; Smart Cycler, Cepheid, Sunny-
vale, CA) in the presence of 0.2× SYBR green I (Molecular
Probes). Transcripts of 18S rRNA and mRNA for the K+
channels KCNJ10, KCNQ1 and KCNQ4 were amplified
using gene-specific primers (Table 1). RT was performed
for 30 min at 50°C and 15 min at 95°C. PCR consisted of
50 cycles of 1 min at 60°C, 1 min at 72°C, 7s heating to
hot-measurement temperature, 13s hot-measurement at
3–5°C below product melting temperature (Table 1) and
1 min at 94°C. Hot-measurements were performed to
eliminate the detection of primer-dimers that had melting
temperatures between 72 and 75°C [15]. PCR was fol-
lowed by a melt (60 to 95°C). The generation of a single
product of appropriate size was routinely checked by the
presence of a single melt peak and by agarose gel-electro-
phoresis. Product identity was confirmed by sequencing.
Template molecules (T) were quantified according to T =
P / (F ^Ct) where P is the number of product molecules, F
is the fidelity of the reaction and Ct is the cycle at which
the number of product molecules reaches a chosen thresh-
old [15]. Fidelity (F) was obtained from the slope (S) of
the log-linear phase of the growth curve via a best-fit fifth-
order polynomial: F = 7.39 + 3.80 × S + 1.05 × S2 + 0.15 ×
S3 + 11.38 × 10-3 * S4 + 3.39 × 10-4 × S5. The number of
product molecules at threshold (PCt) was determined by
amplification of known amounts of 18S rRNA according
to PCt = T × F ^Ct. Quantifications of 18S rRNA were used
to compare tissue amounts. Genomic contamination of
inner ear samples was assessed to be <0.02% by omission
of the RT step.
In vitro electrophysiology
Animals were deeply anesthetized with sodium pentobar-
bital (100 mg/kg i.p.). Stria vascularis without spiral liga-
ment was obtained by microdissection. Currents
generated by the stria marginal epithelium were recorded
[16]. A Pt-Ir wire microelectrode with a Pt-black tip was
positioned 20–30 µm from the apical surface of the epi-
thelium and vibrated at 200–400 Hz by piezo-electric
bimorph elements (Applicable Electronics, Forest Dale,
MA; ASET version 1.05, Science Wares, East Falmouth,
MA). A Pt-black electrode (26-gauge) served as reference
in the bath chamber. The signals from the phase-sensitive
detectors were digitized (16 bit) at a rate of 0.5 Hz. The
output was expressed as current density at the electrode.
In situ electrophysiology
Animals were anesthetized with inactin (thiobutabarbital
sodium salt, 140 mg/kg ip). The endocochlear potential
and the endolymphatic [K+] were measured with double-
barreled microelectrodes [17]. Measurements were made
in the basal turn by a round-window approach through
the basilar membrane and in the apical turn after thinning
the bone over the stria vascularis and picking a small hole
(~30 µm). K+-selective electrodes were calibrated in solu-
tions of constant cation (K+ and Na+) concentration of
150 mM. The minor selectivity of the K+ electrodes for Na+
produced a nonlinearity in the calibration curve, which
was closely fitted by the Nicolski equation using nonlin-
ear curve-fitting software (OriginLab, Northampton, MA):
V = Vi + S × log ([K+] + A × [Na+]), where Vi is an offset
term, S is slope, A is selectivity, and [Na+] is Na+ concen-
tration. Calibrations were made immediately after with-
drawal of the electrodes from the cochlea. Plasma K+
concentrations were obtained using a blood analyzer (Stat
Profile M, Nova Biomedical, Waltham, MA).
Table 1: Primers
Template Primers Product 
Length
Melting 
Temperature
Hot 
Measurement
Fidelity n
18S gag gtt cga aga cga tca ga (sense) 316 bp 83.2 ± 02°C 78°C 1.89 ± 0.02 17
tcg ctc cac caa cta aga ac (antisense)
KCNJ10 tgg tgt ggt gtg gta tct gg (sense) 411 bp 83.2 ± 02°C 78°C 1.86 ± 0.02 15
tga agc agt ttg cct gtc ac (antisense)
KCNQ1 ttt gtt cat ccc cat ctc ag (sense) 239 bp 82.5 ± 02°C 79°C 1.85 ± 0.02 17
gtt gct ggg tag gaa gag (antisense)
KCNQ4 ccc gga aac cct tct gtg tc (sense) 245 bp 83.2 ± 02°C 80°C 1.87 ± 0.01 17
aaa gat gag cac cag gaa cc (antisense)BMC Medicine 2004, 2:30 http://www.biomedcentral.com/1741-7015/2/30
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Data are presented as mean ± sem; n denotes the number
of experiments. Differences were considered significant
when p < 0.05.
Results and Discussion
In situ hybridization in the cochlea has suggested that pen-
drin mRNA is expressed in cells that reside immediately
beneath the spiral prominence on the lateral wall of the
external sulcus [8]. To determine the location of pendrin
protein expression, we performed confocal immunocyto-
chemistry on cryosections prepared from temporal bones
of normal (Slc26a4+/+) mice using an established antibody
[3]. Staining was absent when the primary antibody was
pre-absorbed with the antigenic peptide (data not shown).
Strong expression of pendrin was observed not only in
outer sulcus epithelial cells, as predicted from in situ
hybridization data, but also in root cells, in apical mem-
branes of spiral prominence surface epithelial cells and in
apical membranes of spindle-shaped cells that are part of
stria vascularis (Fig. 1a,1b,1c). The presence of pendrin in
spindle-shaped cells suggests that these cells secrete HCO3
- into endolymph. Pendrin-mediated HCO3 
- transport has
previously been shown in the kidney [9]. HCO3 
- in the
cochlea may be generated from CO2 by carbonic anhy-
drase located in strial intermediate cells [18,19]. CO2 may
be supplied by the metabolically highly active stria mar-
ginal cells. It is conceivable that pendrin dysfunction
interrupts HCO3 
- secretion and leads to an accumulation
of HCO3 
- in stria vascularis. Preliminary data (Wange-
mann et al., unpublished) support a role for pendrin in
HCO3 
- secretion into endolymph.
The extent of pendrin expression in spiral prominence
cells and stria vascularis was determined by labeling
KCNQ1, a K+ channel that is expressed in strial marginal
cells, and ZO-1, a tight junction protein that labels basal
cells and thereby delineates the boundaries of stria vascu-
laris. Dual labeling experiments demonstrated that pen-
drin is expressed in spindle-shaped cells, which are surface
epithelial cells in stria vascularis adjacent to strial mar-
ginal cells near the borders of both the spiral prominence
and Reissner's membrane (Fig. 1c).
In situ hybridization in the vestibular labyrinth suggested
that pendrin mRNA is expressed in non-sensory cells [8].
Using confocal immunocytochemistry on cryosections,
we observed strong expression of the pendrin protein in
the apical membrane of vestibular transitional cells in the
utricle and ampullae (Fig. 1g,1h,1i). Dual labeling with
KCNQ1 demonstrated that pendrin expression was clearly
limited to vestibular transitional cells and did not extend
to other non-sensory cells such as vestibular dark cells,
which were clearly identified by the expression of KCNQ1
and KCNE1 in their apical membranes.
The onset of pendrin expression during development of
the mouse inner ear has been determined to be embryonic
day (ED) 13 [14]. Morphologically detectable differences
in the inner ears of Slc26a4+/+ and Slc26a4-/- mice become
evident as early as ED 15, when Slc26a4-/- mice start to
develop an enlarged endolymphatic space that persists
into adulthood [14]. Interestingly, sensory hair cells in the
cochlea appear normal until postnatal day (PD) 7 but
show clear evidence of degeneration by PD 15 [14]. These
observations suggest that the cochlear environment sup-
ports the survival of sensory hair cells in spite of the
enlargement of the endolymphatic duct. A normal endol-
ymphatic K+ concentration, which is critical for hair cell
survival [20], is established at PD 3 [21] and may persist
in Slc26a4-/- at least until PD 7. The time period between
PD 7 and 15 is the time when the endocochlear potential
develops at the onset of hearing [22]. We hypothesized
that a lack of a normal endocochlear potential or an alter-
ation of the endolymphatic K+  concentration could
account for deafness in Slc26a4-/- mice. Measurements
revealed that the endocochlear potential was absent but
that the endolymphatic K+ concentration was normal in
adult  Slc26a4-/-  (Fig. 2a). No significant differences
between Slc26a4+/+ and Slc26a4-/- mice were found in per-
ilymphatic (Fig. 2a) or plasma K+  concentrations
(Slc26a4+/+, 4.9 ± 0.3 mM, n = 6; Slc26a4-/-, 5.1 ± 0.3 mM,
n = 6). These observations suggest that a primary event
leading to deafness in Slc26a4-/- mice, and potentially in
patients suffering from Pendred syndrome, is the loss of
the endocochlear potential. Degeneration of hair cells is
probably a response to the loss of the endocochlear
potential.
The endocochlear potential is generated by stria vascularis
in the lateral wall of the cochlea [17,23]. The potential is
generated across the basal cell barrier of stria vascularis by
the K+ channel KCNJ10 located in intermediate cells [24],
which are connected to basal cells by a high density of gap
junctions [25]. Marginal cells of stria vascularis, which
form the barrier toward endolymph, transport K+ from the
intrastrial space into endolymph and keep the K+ concen-
tration low adjacent to the KCNJ10 K+ channel [26]. To
determine the cause of the loss of the endocochlear
potential in Slc26a4-/- mice, we first determined whether
intermediate cells are present in stria vascularis, since a
loss of intermediate cells is known to lead to a loss of the
endocochlear potential [27,28]. Intermediate cells of stria
vascularis were visualized by their pigmentation. Pigmen-
tation was present in stria vascularis of Slc26a4-/- mice
(Fig. 2b), which suggests that intermediate cells are
present. Interestingly, pigmentation of stria vascularis was
much stronger in Slc26a4-/- than in Slc26a4+/+ mice.BMC Medicine 2004, 2:30 http://www.biomedcentral.com/1741-7015/2/30
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Protein localization of pendrin, KCNQ1, ZO-1 and F actin in cochlea and vestibular labyrinth of Slc26a4+/+ and Slc26a4-/- mice Figure 1
Protein localization of pendrin, KCNQ1, ZO-1 and F actin in cochlea and vestibular labyrinth of Slc26a4+/+ and Slc26a4-/- mice. 
a: Overview of cochlea; bar = 100 µm. b-f: Detail of cochlear lateral wall; bar = 10 µm. g: Detail of utricle; bar = 10 µm. h-i: 
Detail of ampulla; bar = 10 µm. RM, Reissner's membrane; SC, spindle-shaped cells, SMC, strial marginal cells; SV, stria vascula-
ris; SL, spiral ligament; LIM, spiral limbus. BC, basal cells; SP, spiral prominence epithelial cells; RC, root cells; OS, outer sulcus 
epithelial cells; VHC, vestibular hair cells; VTC, vestibular transitional cells; VDC, vestibular dark cells; arrows, basal cells at the 
top and bottom of stria vascularis form tight junctions with surface epithelial cells.
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To determine in greater detail the cause of the loss of the
endocochlear potential in Slc26a4-/-  mice, we isolated
total RNA from stria vascularis and spiral ganglia of young
(1–4 month) Slc26a4+/+ and both young and old (~12
month) Slc26a4-/- mice, assessed amounts of isolated tis-
sues by quantification of 18S rRNA, and quantified the
expression of KCNJ10 mRNA. Quantities of stria vascula-
ris isolated from these different mice were similar, since
no significant differences were found in the numbers of
18S rRNA molecules (log(rRNA) = 9.46 ± 0.08, n = 17,
pooled data). In contrast, quantities of spiral ganglia iso-
lated from young and old Slc26a4-/- mice (log(rRNA) =
9.04 ± 0.18, n = 4 and 9.29 ± 0.15, n = 6) were signifi-
cantly smaller than in Slc26a4+/+ mice (log(rRNA) = 9.48
± 0.19, n = 7), consistent with morphometric data (see
below). Expression of KCNJ10 mRNA was normal in stria
vascularis and spiral ganglia of young Slc26a4-/- mice but
significantly reduced in old Slc26a4-/- mice (Fig. 3). Quan-
Potential, K+ concentrations and pigmentation of stria vascularis in Slc26a4+/+ and Slc26a4-/- mice Figure 2
Potential, K+ concentrations and pigmentation of stria vascularis in Slc26a4+/+ and Slc26a4-/- mice. a: Endocochlear potential and 
K+ concentrations in endolymph and perilymph at the apex (A) and base (B) of the cochlea. Numbers adjacent to symbols 
denote number of measurements. b-d: Pigmentation of stria vascularis in Slc26a4+/+ and Slc26a4-/- mice. b: View of stria vascu-
laris through the bony capsule of the cochlea. OW, oval window, RW, round window; arrows, stria vascularis. c-d: Whole-
mounts of stria vascularis isolated from age-matched mice. c: Laser-scanning images, bar = 10 µm, d: Quantification of pigmen-
tation based on optical density.
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tifications of KCNQ1 and KCNQ4 mRNA were used to
assess possible cross-contamination between the stria vas-
cularis and spiral ganglia preparations based on the
assumptions that (1) KCNQ1 is expressed in cells of the
stria vascularis but not the spiral ganglia preparation and
(2) KCNQ4 is expressed in cells of the spiral ganglia but
not the stria vascularis preparation. The number of
KCNQ1 mRNA molecules in stria vascularis was 24-fold
greater than in spiral ganglia, and the number of KCNQ4
mRNA molecules in spiral ganglia was 5-fold greater than
in stria vascularis. These observations validate our meas-
urements of KCNJ10 and KCNQ1 by demonstrating that
the microdissected preparations of stria vascularis and spi-
ral ganglia were 98% and 78% pure, respectively.
Quantification of KCNJ10 and KCNQ1 mRNA expression in stria vascularis and spiral ganglia of Slc26a4+/+ and Slc26a4-/- mice Figure 3
Quantification of KCNJ10 and KCNQ1 mRNA expression in stria vascularis and spiral ganglia of Slc26a4+/+ and Slc26a4-/- mice. 
a: Electropherogram of total RNA isolated from stria vascularis microdissected from one mouse. The amount of total RNA 
was obtained from the total integral (shaded) and the amount of 18S rRNA was obtained from the integral of the 18S peak. 
Sharp peaks representing 18S and 28S rRNA demonstrate the high quality of RNA. Insert: Genotype of Slc26a4-/- mice was 
verified by the observation of one or few very large rhomboedric otoconia in the utricular macula (arrow). A, crista ampullaris; 
U, utricular macula. Scale bar: 100 µm. b: Example of real-time RT-PCR data used for quantification of 18S, KCNJ10, KCNQ1 
and KCNQ4. Known quantities of 18S rRNA were used to calibrate the threshold. SV, stria vascularis; SG, spiral ganglia. c: 
Quantification of KCNJ10 and KCNQ1 mRNA in young Slc26a4+/+ and young and old Slc26a4-/- mice.
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The presence of KCNJ10 mRNA in stria vascularis of
Slc26a4-/- mice supports the finding that intermediate cells
are present. Expression of the KCNJ10 protein was
assessed in young Slc26a4-/- mice by confocal immunocy-
tochemistry. Interestingly, expression of the KCNJ10 pro-
tein was absent in stria vascularis but normal in spiral
ganglia (Fig. 4). The absence of the KCNJ10 K+ channel in
stria vascularis is sufficient to explain the loss of the endo-
cochlear potential [17].
Histological evaluation of cryosections revealed an
enlargement of scala media with a large bulging of Reiss-
ner's membrane and an apparent degeneration of the
organ of Corti, as described earlier [14]. Tissue height of
stria vascularis was normal (Fig. 5), consistent with the
similar numbers of 18S rRNA molecules in isolated prep-
arations (see above). The absence of a change in tissue
height is consistent with the presence of intermediate cells
[28]. Further, we observed an apparent loss of tissue
masses in areas that are normally occupied primarily by
type I and II fibrocytes. Spiral prominence in Slc26a4-/-
mice was less prominent, spiral ligament thinner and spi-
ral limbus flatter (Fig. 5). The observation that tissue
masses were lost in the spiral limbus region is consistent
with the finding of a reduced number of 18S rRNA mole-
cules in the spiral ganglia preparation (see above). In addi-
tion, we observed an apparent degeneration of stria
vascularis, including an increase in pigmentation and an
irregular pattern of the tight junctions of marginal cells
(Fig. 2c, 6,7). Tight junctions were visualized by F-actin
expression. Marginal cells appeared to form a continuous
layer.
Pendrin-expressing surface epithelial cells in the spiral
prominence region are located in an area where basal
cells, which are interconnected by tight junctions, form
additional tight junctions with surface epithelial cells
[29]. A discontinuity of this complex junction in Slc26a4-
/- mice would explain the absence of the endocochlear
potential. To evaluate the presence of this connection, we
determined by confocal immunocytochemistry the
expression of ZO-1 and of F-actin, which associate with
tight junction complexes. ZO-1 and F-actin expression
revealed a continuous layer of basal cells, including a
junction of basal cells with surface epithelial cells in
Slc26a4-/-  mice, as observed in normal mice (Fig.
1c,1d,1e,1f,6,7). These observations make it unlikely that
the primary cause of the loss of the endocochlear poten-
tial is a compromise in the basal cell barrier.
Protein localization of KCNJ10 in the cochlea of Slc26a4+/+ and Slc26a4-/- mice Figure 4
Protein localization of KCNJ10 in the cochlea of Slc26a4+/+ and Slc26a4-/- mice. a: Overview of cochlea; bar = 100 µm. Com-
pare to Fig. 1a to note the enlarged scala media and the distended Reissner's membrane. b-c: Detail of lateral wall and spiral 
ganglia (insert); main bar: 10 µm, insert: 5 µm. Expression of KCNJ10 in Slc26a4-/- mice was absent in stria vascularis but 
unchanged in spiral ganglion cells. RM, Reissner's membrane, SV, stria vascularis; SP, spiral prominence; SL, spiral ligament; LIM, 
spiral limbus; SG, spiral ganglion.
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The observation that endolymphatic and perilymphatic
K+ concentrations were normal in Slc26a4-/- mice suggests
that stria vascularis was able to secrete K+ in spite of the
apparent signs of degeneration. The rate of K+ secretion
necessary to maintain endolymphatic K+ concentration,
however, may be less than necessary in Slc26a4+/+ mice
given the reduced numbers of sensory hair cells, which
provide a major pathway for K+ exit from endolymph
[30,31]. In order to substantiate the view that stria vascu-
laris in Slc26a4-/- secretes K+, we measured the magnitude
of the bumetanide-sensitive current exiting stria vascularis
across the apical membrane of strial marginal cells and
determined the expression of the proteins KCNQ1,
KCNE1 and SLC12A2, which are essential for K+ secretion
[20,32,33], and of GJB2 (Cx26), which is thought to con-
tribute to K+ cycling [23]. K+ secretion is known to be sen-
sitive to 10-5 M bumetanide, a loop-diuretic that inhibits
the Na+/2Cl-/K+  cotransporter SLC12A2 [26]. Bumeta-
nide-sensitive currents were found in both Slc26a4+/+ and
Slc26a4-/- mice although the magnitude of the current was
significantly smaller in Slc26a4-/- mice (22 ± 6 µA/cm2, n
= 4 versus 14 ± 2 µA/cm2, n = 4). KCNQ1 and KCNE1,
subunits of the secretory K+ channel, were co-localized in
the apical membrane of strial marginal cells; the Na+/2Cl-
/K+ cotransporter SLC12A2, which is located in the baso-
lateral membrane of strial marginal cells, was found in
stria vascularis; and the gap junction protein GJB2 was
found in spiral ligament of Slc26a4+/+ and Slc26a4-/- mice
(Fig. 8). Co-localization of KCNQ1 and KCNE1 proteins
was also observed in vestibular dark cells (Fig. 1i). Expres-
sion of KCNQ1 protein in stria vascularis of Slc26a4-/-
mice is consistent with the finding of KCNQ1 mRNA
expression (Fig. 3). These observations make it unlikely
that the primary cause of the loss of the endocochlear
potential is a compromise of K+ secretion by strial mar-
ginal cells or a compromise of gap junction mediated K+
cycling.
Conclusions
We described locations of pendrin expression in the coch-
lea and vestibular labyrinth and detected normal
endolymphatic K+ concentrations in spite of an enlarge-
ment of this fluid compartment. We found that Slc26a4-/-
mice lack the endocochlear potential because they do not
Morphometric analysis of cochlear tissue masses in Slc26a4+/+ and Slc26a4-/- mice Figure 5
Morphometric analysis of cochlear tissue masses in Slc26a4+/+ and Slc26a4-/- mice. a: locations of measurements. Thickness of 
stria vascularis (SV) was obtained as average of three distance measurements perpendicular to the surface of marginal cells. 
Thickness of spiral prominence (SP) was measured perpendicular to a tangential line (dashed) that connects the surface of the 
outer sulcus (OS) with the basal layer of stria vascularis. Thickness of spiral ligament (SL) was measured perpendicular to the 
tangential line as distance between the surface of spiral prominence and the interface between spiral ligament and bone (B). 
Thickness of spiral limbus (LIM) was obtained perpendicular to the surface of the bone as a tangential line that touches the 
inner sulcus (IS) and reaches from the surface of the spiral limbus to the interface between spiral limbus connective tissue and 
bone. b: Summary. Data from 7–8 animals contributed to each column.
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Analysis of marginal and basal cell barriers by in Slc26a4-/- mice Figure 6
Analysis of marginal and basal cell barriers by in Slc26a4-/- mice. Tight junctions were visualized by F actin. Whole-mounts of 
stria vascularis were viewed either from the basal cell side (a-f) or from the marginal cell side (g-l). Bright field images verify 
that the same area was viewed from either side (b and h). Colored bright field images were mixed with images of F actin stain-
ing to indicate the position of pigment granules (d, j, f and l). Focus was varied to either visualize the marginal cell barrier 
(SMC, c-d and i-j) or the basal cell barrier (BC, e-f and k-l). Both the marginal cell (e-f) and the basal cell barrier (i-f) appeared 
to be intact. It was critical for this finding that pigmentation did not block the path of the laser. Blockage of the laser by pigmen-
tation produces the untrue impression of a discontinuous marginal cell barrier (c-d) or basal cell barrier (k-l). Comparison of 
images is aided by marking a significant area with a star. Bars = 10 µm.
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Analysis of marginal and basal cell barriers in Slc26a4+/+ and Slc26a4-/- mice Figure 7
Analysis of marginal and basal cell barriers in Slc26a4+/+ and Slc26a4-/- mice. Tight junctions were visualized by F actin in whole-
mounts of stria vascularis. Bright field images were taken to evaluate pigmentation (a, d and g). Note the intact marginal cell 
(b) and basal cell (c) barriers in Slc26a4+/+ mice. Minimal pigmentation of Slc26a4+/+ mice did not compromise F actin localiza-
tion. Whole-mounts of stria vascularis from Slc26a4-/- mice were viewed either from the basal cell side (e-f) or from the mar-
ginal cell side (h-i). Bright field images verify that the same area was viewed from either side (d and g). Focus was varied to 
either visualize the marginal cell barrier (SMC, b,e and h) or the basal cell barrier (BC, c,f and i). Both the basal cell (f) and the 
marginal cell (h) barriers appeared to be intact. Blockage of the laser by pigmentation produces the untrue impression of 
'holes' in the marginal cell barrier (e) or basal cell barrier (i). Comparison of images is aided by marking three significant areas 
with colored stars. Bars = 10 µm.
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express KCNJ10 protein. Intermediate cells protect stria
vascularis by converting CO2 to HCO3 
- and by detoxifying
free radicals (Fig. 9). CO2 and free radicals are generated
by the large numbers of mitochondria in the metaboli-
cally highly active strial marginal cells. Intermediate cells
employ carbonic anhydrase to convert CO2 to HCO3 
-
[18,19] and catalase to detoxify free radicals. To protect
themselves from free radical damage, intermediate cells
generate glutathione and melanin pigment [34-37]. It is
conceivable that loss of pendrin, which may secrete HCO3
- into endolymph, results in an accumulation of HCO3 
-
and an alkalinization of the intrastrial spaces. This extra-
cellular alkalinization may enhance free radical stress,
since it may inhibit the uptake of cysteine and thereby
limit production of the protective glutathione [38]. Sup-
port for the hypothesis of enhanced free radical stress
comes from the observed hyperpigmentation in mice
lacking pendrin. Strial hyperpigmentation has also been
observed in other conditions that are associated with free
radical stress, such as acoustic trauma [37]. Alterations in
the cytosolic pH in conjunction with free radical stress
may lead to the loss of KCNJ10 protein expression in strial
intermediate cells. Function and expression of other K+
channels has been shown to be controlled by the cytosolic
pH and free radicals, which encode the metabolic state of
the cell [39]. Suppression of the KCNJ10 K+ channel in
strial intermediate cells, which is essential for the genera-
tion of the endocochlear potential, is probably the direct
cause of deafness in Slc26a4-/- mice and patients suffering
from Pendred syndrome.
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Protein localization of KCNQ1, KCNE1, SLC12A2 and GJB2 in the cochlear lateral wall of Slc26a4+/+ and Slc26a4-/- mice Figure 8
Protein localization of KCNQ1, KCNE1, SLC12A2 and GJB2 in the cochlear lateral wall of Slc26a4+/+ and Slc26a4-/- mice. a-f: 
bars: 10 µm. SMC, strial marginal cells; SV, stria vascularis; BC, basal cells; SL, spiral ligament.
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Model for the loss of KCNJ10 in the absence of pendrin expression in stria vascularis Figure 9
Model for the loss of KCNJ10 in the absence of pendrin expression in stria vascularis. Cys, cysteine, Glu, glutamate, Gly, gly-
cine, CA, carbonic anhydrase, GST, glutathione-S-transferase, GSH, glutathione.
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